Cargando…
Montelukast and Acute Coronary Syndrome: The Endowed Drug
Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation of the leukotriene (LT) pathway with subsequent releases of various LTs, including LTB4, LTC4, and LTD4, which cause inflam...
Autores principales: | Alomair, Basil Mohammed, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Al-Hamash, Sadiq M., De Waard, Michel, Sabatier, Jean-Marc, Saad, Hebatallah M., El-Saber Batiha, Gaber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500901/ https://www.ncbi.nlm.nih.gov/pubmed/36145367 http://dx.doi.org/10.3390/ph15091147 |
Ejemplares similares
-
The role of berberine in Covid-19: potential adjunct therapy
por: Babalghith, Ahmad O., et al.
Publicado: (2022) -
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
por: Babalghith, Ahmad O., et al.
Publicado: (2022) -
Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
por: Alsubaie, Nawal, et al.
Publicado: (2022) -
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?
por: Alomair, Basil Mohammed, et al.
Publicado: (2022)